3 Big Pharma Stocks to Buy Right Now
These big pharma stocks all have a Zacks Rank #2 or better. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report&nb.....»»
Eli Lilly Rated Top in Innovation, Bristol-Myers Leader in Invention
IDEA Pharma rates drug companies in both categoriesRelated Stocks: LLY, BMY, RHHBY, AMGN, TEVA, REGN, SEGN, INCY, GSK, SNY, AZN,.....»»
Ascendis Pharma A/S Stock Shows Every Sign Of Being Modestly Undervalued
Related Stocks: ASND,.....»»
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma"s Epidiolex
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) read more.....»»
10 Cheap Pharmaceutical Stocks For 2021
In this article we will take a look at the 10 cheap pharmaceutical stocks for 2021. You can skip our comprehensive analysis of the pharma indu.....»»
5 Cheap Pharmaceutical Stocks For 2021
In this article we will take a look at the 5 cheap pharmaceutical stocks for 2021. For a detailed analysis of the pharma industry, go direc.....»»
Royalty Pharma Plc (RPRX) EVP, Research & Investments James F. Reddoch Sold $2. ...
Related Stocks: RPRX,.....»»
The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 22) Acceleron Pharma Inc (NASDAQ: XLRN) Akari Therapeutics PLC (NASDAQ: AKTX) Annexon Inc (NASDAQ: ANNX).....»»
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all served to lift stocks higher. read more.....»»
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vac.....»»
The Week In Cannabis: Stocks Up By Double-Digits On Jazz Pharma"s GWPH Acquisition, Potential Federal Moves
Cannabis stocks had one of their strongest weeks in history. Jazz .....»»
The Week In Cannabis: Stocks Up By Double-Digits On Jazz Pharma"s GWPH Acquisition, Potential Federal Moves
Cannabis stocks had one of their strongest weeks in history. read more.....»»
Cannabis Watch: Cannabis stocks rally anew as $7 billion GW Pharma deal spurs interest in weed and its medical benefits
Cannabis stocks rallied anew on Wednesday, spurred on by news of a $7 billion deal for the first company to win U.S. regulatory approval for a cannabis-based drug, a move that's expected to boost investor interest in the plant and its medical benefits......»»
The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More
Biopharma stocks advanced yet again in the week ended Jan. 22, with the change of guard at the White House generating broader market strength. read more.....»»
After Drug Failure, Genfit"s Cupboard Is Nearly Bare
Company’s high hopes for NASH drug stymied, providing opening for Intercept Pharma treatmentRelated Stocks: GNFT, ICPT, GILD, PXSLY, GLMD, ROCO:6549, MDGL, AGN,.....»»
32 Stocks Moving in Thursday"s Pre-Market Session
Gainers BioPharmX Corporation (NYSE: BPMX) shares rose 56.4% to $0.73 in pre-market trading after the company reported approval of merger with Timber Pharma by shareholders. read more.....»»
The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) read more.....»»
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.) read more.....»»
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc. read more.....»»
Big Pharma Short Sellers Can’t Make Up Their Minds
The April 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed......»»
The Daily Biotech Pulse: FDA Approves Sanofi"s Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs April 23.) Arcturus Therapeutics .....»»